Rafferty Asset Management, LLC Praxis Precision Medicines, Inc. Transaction History

Rafferty Asset Management, LLC

  • $26.7 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$1.75 - $11.34 $279,357 - $1.81 Million
159,633 Added 227.37%
229,840 $563,000
Q1 2022

May 13, 2022
BUY
$10.21 - $20.29 $27,730 - $55,107
2,716 Added 4.02%
70,207 $717,000
Q4 2021

Feb 10, 2022
BUY
$16.76 - $22.99 $1.13 Million - $1.55 Million
67,491 New
67,491 $1.33 Million
Q2 2021

Aug 10, 2021
SELL
$18.28 - $33.05 $687,218 - $1.24 Million
-37,594 Closed
0 $0
Q1 2021

May 10, 2021
BUY
$29.34 - $60.2 $1.1 Million - $2.26 Million
37,594 New
37,594 $1.23 Million

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0
View Full List

About Praxis Precision Medicines, Inc.

PRAX Quotes by TradingView
  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $1.84B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email